Mark Sheptoff Financial Planning’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$734K Sell
5,502
-149
-3% -$20.9K 0.39% 47
2025
Q4
$694K Buy
+5,651
New +$687K 0.33% 49
2019
Q1
Sell
-217
Closed -$14K 356
2018
Q4
$14K Buy
217
+2
+0.9% +$140 0.01% 212
2018
Q3
$17K Buy
215
+1
+0.5% +$76 0.01% 250
2018
Q2
$15K Sell
214
-8,673
-98% -$612K 0.01% 244
2018
Q1
$670K Sell
8,887
-1,131
-11% -$89.9K 0.46% 53
2017
Q4
$718K Sell
10,018
-3,824
-28% -$290K 0.47% 57
2017
Q3
$1.12M Sell
13,842
-449
-3% -$34.3K 0.75% 38
2017
Q2
$1.01M Sell
14,291
-649
-4% -$43.2K 0.69% 41
2017
Q1
$1.01M Sell
14,940
-173
-1% -$12.2K 0.72% 39
2016
Q4
$1.08M Sell
15,113
-700
-4% -$52K 0.8% 36
2016
Q3
$1.25M Sell
15,813
-1,074
-6% -$87.2K 0.93% 31
2016
Q2
$1.41M Buy
16,887
+1,000
+6% +$88.7K 1.05% 29
2016
Q1
$1.46M Buy
15,887
+2,204
+16% +$199K 1.19% 25
2015
Q4
$1.39M Sell
13,683
-475
-3% -$49.4K 1.12% 24
2015
Q3
$1.39M Buy
14,158
+4,660
+49% +$518K 1.22% 23
2015
Q2
$1.11M Buy
9,498
+4,200
+79% +$459K 0.9% 33
2015
Q1
$520K Sell
5,298
-900
-15% -$91.4K 0.43% 56
2014
Q4
$584K Buy
6,198
+100
+2% +$10.3K 0.52% 57
2014
Q3
$649K Buy
6,098
+2,400
+65% +$235K 0.57% 53
2014
Q2
$307K Buy
3,698
+490
+15% +$38.1K 0.26% 85
2014
Q1
$227K Buy
+3,208
New +$252K 0.2% 98

Other funds holding GILD

Mark Sheptoff Financial Planning's GILD Position: Q1 2026 in Review

Mark Sheptoff Financial Planning reduced its Gilead Sciences (GILD) stake by 2.6% in Q1 2026, selling an estimated $20.9K and leaving 5,502 shares worth $734K. The position accounts for 0.39% of the portfolio, ranked #47.

Mark Sheptoff Financial Planning first reported a position in GILD in Q1 2014 and has held it in 22 quarters since. The position peaked at $1.46M in Q1 2016. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Mark Sheptoff Financial Planning held 5,502 shares of Gilead Sciences worth $734K as of Q1 2026.
  • Mark Sheptoff Financial Planning sold 149 Gilead Sciences shares in Q1 2026, an estimated $20.9K.
  • Gilead Sciences made up 0.39% of Mark Sheptoff Financial Planning's portfolio in Q1 2026, its #47 holding.
  • Mark Sheptoff Financial Planning first reported a position in Gilead Sciences in Q1 2014 and has held it in 22 quarters since.
  • Mark Sheptoff Financial Planning's Gilead Sciences position peaked at $1.46M in Q1 2016.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Mark Sheptoff Financial Planning's 13F filing for Q1 2026, filed 11 May 2026.